(Q53152606)

11 May 2018

title

Immunotherapy against invasive fungal diseases in stem cell transplant recipients. (English)

1 reference

11 May 2018

1 reference

3

1 reference

11 May 2018

Thomas Klingebiel

6

Thomas Klingebiel

1 reference

11 May 2018

Thomas Lehrnbecher

1

Thomas Lehrnbecher

1 reference

11 May 2018

Lars Tramsen

2

Lars Tramsen

1 reference

11 May 2018

Konrad Bochennek

5

Konrad Bochennek

1 reference

11 May 2018

author name string

Stanislaw Schmidt

4

1 reference

11 May 2018

publication date

31 May 2011

1 reference

11 May 2018

Immunological Investigations

published in

1 reference

11 May 2018

volume

40

1 reference

11 May 2018

issue

7-8

1 reference

11 May 2018

page(s)

839-852

1 reference

11 May 2018

Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation.

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Invasive fungal infection in haematopoietic stem cell transplant recipients: epidemiology from the transplant physician's viewpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Intestinal mucosal dysfunction and infection during remission-induction therapy for acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Risk factors for invasive fungal infections in haematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

T cell vaccination in mice with invasive pulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Changes in host defence induced by malignancies and antineoplastic treatment: implication for immunotherapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Haematopoietic growth factors in children with neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Prophylactic human granulocyte colony-stimulating factor after induction therapy in pediatric acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Provision of antifungal immunity and concomitant alloantigen tolerization by conditioned dendritic cells in experimental hematopoietic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Early NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Immunity to fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Controlling pathogenic inflammation to fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Granulocyte-colony-stimulatory factor: a strong inhibitor of natural killer cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Human natural killer cells exhibit direct activity against Aspergillus fumigatus hyphae, but not against resting conidia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Randomized phase III study of granulocyte transfusions in neutropenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Palifermin for oral mucositis after intensive therapy for hematologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Decreased infections in recipients of unrelated donor hematopoietic cell transplantation from donors with an activating KIR genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Generation and characterization of anti-Candida T cells as potential immunotherapy in patients with Candida infection after allogeneic hematopoietic stem-cell transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Keratinocyte growth factor is effective in the prevention of intestinal mucositis in patients with hematological malignancies treated with high-dose chemotherapy and autologous hematopoietic SCT: a video-capsule endoscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Infections due to emerging and uncommon medically important fungal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

Immune Sensing of Aspergillus fumigatus Proteins, Glycolipids, and Polysaccharides and the Impact on Th Immunity and Vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2011.581732

10.3109/08820139.2011.581732

21 January 2018

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018